United States · FDA National Drug Code directory
Cetirizine Hydrochloride (Allergy)
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 21130-099_b3b261a6-e56a-458a-a5a4-92bd95f4e2fc
- Product NDC
- 21130-099
- Form
- CAPSULE
- Composition / generic term
- Cetirizine Hydrochloride
- Labeler
- Better Living Brands, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20231115
- Source listing expiry
- 20261231
Source-listed ingredients
- CETIRIZINE HYDROCHLORIDE — 10 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE in 1 CARTON (21130-099-97) / 25 CAPSULE in 1 BOTTLE · 21130-099-97
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →